Cingulate
Most recent annual filing: 2026-03-18
Pipeline (1 active programs)
Technology platforms
PTR · BDD Pharma
Precision Timed Release (PTR) drug delivery platform — proprietary multi-core tablet technology incorporating an Erosion Barrier Layer (EBL) to deliver precisely timed pulsatile drug releases; focus areas: ADHD and anxiety disorders. EBL formulation (Oralogik) licensed from BDD Pharma.
Precision Timed Release
PTR-enabled tri-modal release delivery platform for oral tablets; designed to provide morning onset and sustained active-day coverage in a single once-daily tablet; focus area: ADHD and potentially other CNS conditions
Precision Timed Release · BDD Pharma
PTR drug delivery platform incorporating a proprietary Erosion Barrier Layer (EBL) to control drug release at precise, pre-defined times; designed to enable true once-daily dosing; focus areas include ADHD and anxiety disorders. EBL formulation (Oralogik) licensed from BDD Pharma.
Biotech Distilled coverage (6)
- 2026-08-14 UPDATE: Cingulate (CING) - The Resubmission Nobody Will Date 🔒 Paid
- 2026-06-02 UPDATE: Cingulate (CING) - The CRL Lands, the Tripwire Arms
- 2026-05-15 UPDATE: Cingulate (CING) - The CMC Shoe Drops 17 Days Before PDUFA
- 2026-04-05 UPDATE: Cingulate (CING) - Institutional Adult Supervision Enters the Boardroom 🔒 Paid
- 2026-03-28 UPDATE: Cingulate (CING) - The Dilution Gap Just Became a Chasm 🔒 Paid
- 2026-03-23 Cingulate (CING) - Scientific Deep Dive on CTx-1301 and Pipeline Products 🔒 Paid
Articles open on Substack. Some deep dives are subscriber-only.